固体癌症中的紧急骨髓形成.
Konstantinos Aliazis1, Sasitorn Yenyuwadee1,2, Ployploen Phikulsod3
1Department of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
British journal of haematology
|July 23, 2024
概括
固体癌症可以通过影响造血干细胞和原生细胞 (HSPCs) 来破坏正常的血细胞生产. 这种干扰可能导致免疫抑制性髓状细胞的发展,影响抗瘤反应.
科学领域:
- 免疫学 免疫学 免疫学
- 血液形成 血液形成 血液形成
- 癌症生物学 癌症生物学
背景情况:
- 免疫细胞起源于造血干细胞和原生细胞 (HSPC).
- 通常情况下,HSPCs会分化和增殖,但在受伤或感染后,它们可以被调动用于紧急骨髓形成.
- 固体瘤可以模仿紧急骨髓形成信号,异常地影响骨髓细胞的发育.
研究的目的:
- 审查有关固体癌症如何影响HSPC功能的文献.
- 讨论这些效应对抗瘤免疫力的潜在影响.
主要方法:
- 文献综述和现有癌症和HSPC相互作用研究的综合.
- 分析瘤影响骨髓形成的机制.
主要成果:
- 固体瘤分泌的因素可以促进骨髓形成.
- 瘤诱导的骨髓形成可以导致免疫抑制性骨髓状细胞的产生.
- 这些对HSPCs的影响发生在系统上,超出瘤微环境.
结论:
- 固体癌症显著影响HSPC功能,重定向髓状细胞的发育.
- 这种异常骨髓形成有助于免疫抑制环境,可能阻碍抗瘤反应.
- 了解这些系统性影响对于开发有效的癌症免疫疗法至关重要.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
318
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
318
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


